ClinicalTrials.Veeva

Menu

A Study of Retrograde Reperfusion of Renal Graft to Reduce Ischemic-reperfusion Injury

W

West Kazakhstan Medical University

Status

Unknown

Conditions

Reperfusion
Kidney Transplantation
Ischemic Reperfusion Injury

Treatments

Procedure: Retrograde renal graft reperfusion
Procedure: Conventional antegrade renal graft reperfusion (without retrograde reperfusion)

Study type

Interventional

Funder types

Other

Identifiers

NCT05179434
116.23.11.2020

Details and patient eligibility

About

To evaluate whether retrograde venous reperfusion of a renal graft before antegrade arterial reperfusion can reduce ischemic-reperfusion injury.

All registered eligible candidates for kidney transplant will be randomized to receive either:

  • retrograde venous, then arterial reperfusion or
  • antegrade arterial reperfusion.

Full description

According to our hypothesis, retrograde venous reperfusion prevents and reduces the immediate and long-term effects of renal allograft ischemic-reperfusion injury.

For the study Chi-square method of sample size estimation with a=0,05, b=0,20 required a 14 subject per group.

The study will include 30 potential kidney recipients for both group aged 18-60 years who will receive kidney transplants. Only adult patients undergoing primary living donor kidney transplantation with standard three-component immunosuppression will be enrolled to the study.The main study group will consist of 15 patients with retrograde graft reperfusion, and control group - will include 15 kidney recipients with only conventional antegrade arterial reperfusion (without retrograde reperfusion).

Patients of the study group with standard kidney implantation surgery will undergo retrograde reperfusion through the renal vein after venous anastomosis. After the venous anastomosis of the graft, an arterial anastomosis is applied with the renal artery without tightening the suture to leave a lumen sufficient for the outflow of retrograde blood. Then the retrograde blood flow through the renal vein is started, venous blood fills the graft and flows through the renal artery through the lumen of the anastomosis in a volume of 80-100 ml. Retrograde blood collected for gas and lactate analysis at the beginning of reperfusion, at the first minute and at the fifth minute. Further, the sutures of the arterial anastomosis are tightened, and after tying, a typical antegrade reperfusion of the graft through the renal artery is performed.

Patients in the control group will undergo standard kidney implantation surgery with typical antegrade arterial reperfusion.

T-test and Mann-Whitney test will be used to compare the median of urea, creatinine levels in serum and glomerular filtration rate (GFR) on the 1st, 7th, 14th, 30th, 60th postoperative day.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with end-stage kidney disease who are ready for kidney transplantation;
  • Panel reactive antibodies (PRA) less than 20%.
  • informed consent to participate in the study.

Exclusion criteria

  • recipients preparing for combined organ transplantation;
  • recipients with previously performed transplantation of another organ;
  • recipients preparing for transplantation with a different immunosuppressive regimen;
  • upcoming blood group incompatibility (AB0-i) transplant;
  • PRA antibodies more than 20%;

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Retrograde graft reperfusion
Experimental group
Description:
Kidney transplantation with retrograde venous reperfusion of renal graft followed by arterial reperfusion
Treatment:
Procedure: Retrograde renal graft reperfusion
conventional antegrade perfusion
Active Comparator group
Description:
Kidney transplantation with conventional arterial reperfusion of renal graft (without retrograde venous reperfusion)
Treatment:
Procedure: Conventional antegrade renal graft reperfusion (without retrograde reperfusion)

Trial contacts and locations

1

Loading...

Central trial contact

Myltykbay Rysmakhanov

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems